Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haimiao Yang

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|August 1, 2023
A randomized, single-blind, single-dose, parallel-group study in healthy subjects to demonstrate the pharmacokinetic equivalence of trastuzumab and its biosimilarYanli Wang, Zhengzhi Liu, Qiaohuan Deng, et al.
Investigational New Drugs|November 28, 2022
Pharmacokinetics and bioequivalence of two pomalidomide capsules in healthy chinese subjects under fasting and fed conditionsZhengzhi Liu, Zhongnan Xu, Zhenyue Gao, et al.
Neural Regeneration Research|February 28, 2015
Overexpression of estrogen receptor beta alleviates the toxic effects of beta-amyloid protein on PC12 cells via non-hormonal ligandsHui Wang, Lihui Si, Xiaoxi Li, et al.
Foods (Basel, Switzerland)|May 27, 2026
Evolution of Rice Storage Quality and Underlying Microstructural Mechanisms Under Varying Nitrogen Fertilization Application LevelsFei Wen, Jiahui Qi, Haimiao Yang, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 8, 2024
A single-dose, randomized, crossover bioequivalence study of levamlodipine besilate tablets in healthy subjectsQiaohuan Deng, Debin Yang, Yang Cheng, et al.
Frontiers in Pharmacology|November 29, 2023
Pharmacokinetics and bioequivalence of sunitinib and Sutent<sup>®</sup> in Chinese healthy subjects: an open-label, randomized, crossover studyYanli Wang, Qiaohuan Deng, Zhenyue Gao, et al.
Clinical Drug Investigation|February 7, 2026
A Single-Center, Randomized, Open-Label, Two-Formulation, Two-Sequence, Two-Period Crossover Study to Evaluate the Bioequivalence of Two Eltrombopag Olamine Tablets (25 mg) in Healthy Chinese Subjects in the Fed StateKeyi Wu, Qin Ren, Yanli Wang, et al.
Frontiers in Medicine|June 11, 2026
Efficacy and safety of vitamin D in the treatment of asthma: an overview of systematic reviews and meta-analysesYongxiu Liu, Jiaheng Lu, Donghao Li, et al.
Expert Opinion on Biological Therapy|June 17, 2021
A randomized, double-blind, single-dose, two-way, parallel phase I clinical study comparing the pharmacokinetics and safety of adalimumab injecta and Humira® in healthy Chinese male volunteersYanli Wang, Zhenyue Gao, Zhengzhi Liu, et al.
Cancer Chemotherapy and Pharmacology|February 9, 2025
Food effect trial of the pharmacokinetics and safety of TQ05105 in healthy Chinese subjectsJun Dai, Yang Cheng, Yannan Zhou, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Expert Opinion on Drug Metabolism & Toxicology|August 1, 2023
A randomized, single-blind, single-dose, parallel-group study in healthy subjects to demonstrate the pharmacokinetic equivalence of trastuzumab and its biosimilarYanli Wang, Zhengzhi Liu, Qiaohuan Deng, et al.
Investigational New Drugs|November 28, 2022
Pharmacokinetics and bioequivalence of two pomalidomide capsules in healthy chinese subjects under fasting and fed conditionsZhengzhi Liu, Zhongnan Xu, Zhenyue Gao, et al.
Neural Regeneration Research|February 28, 2015
Overexpression of estrogen receptor beta alleviates the toxic effects of beta-amyloid protein on PC12 cells via non-hormonal ligandsHui Wang, Lihui Si, Xiaoxi Li, et al.
Foods (Basel, Switzerland)|May 27, 2026
Evolution of Rice Storage Quality and Underlying Microstructural Mechanisms Under Varying Nitrogen Fertilization Application LevelsFei Wen, Jiahui Qi, Haimiao Yang, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 8, 2024
A single-dose, randomized, crossover bioequivalence study of levamlodipine besilate tablets in healthy subjectsQiaohuan Deng, Debin Yang, Yang Cheng, et al.
Frontiers in Pharmacology|November 29, 2023
Pharmacokinetics and bioequivalence of sunitinib and Sutent<sup>®</sup> in Chinese healthy subjects: an open-label, randomized, crossover studyYanli Wang, Qiaohuan Deng, Zhenyue Gao, et al.
Clinical Drug Investigation|February 7, 2026
A Single-Center, Randomized, Open-Label, Two-Formulation, Two-Sequence, Two-Period Crossover Study to Evaluate the Bioequivalence of Two Eltrombopag Olamine Tablets (25 mg) in Healthy Chinese Subjects in the Fed StateKeyi Wu, Qin Ren, Yanli Wang, et al.
Frontiers in Medicine|June 11, 2026
Efficacy and safety of vitamin D in the treatment of asthma: an overview of systematic reviews and meta-analysesYongxiu Liu, Jiaheng Lu, Donghao Li, et al.
Expert Opinion on Biological Therapy|June 17, 2021
A randomized, double-blind, single-dose, two-way, parallel phase I clinical study comparing the pharmacokinetics and safety of adalimumab injecta and Humira® in healthy Chinese male volunteersYanli Wang, Zhenyue Gao, Zhengzhi Liu, et al.
Cancer Chemotherapy and Pharmacology|February 9, 2025
Food effect trial of the pharmacokinetics and safety of TQ05105 in healthy Chinese subjectsJun Dai, Yang Cheng, Yannan Zhou, et al.
Pageof 3